Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial for efficacy and safety of cilostazol on the progression of symptomatic intracranial stenosis comparing clopidogrel

Next Previous
Trial Profile

Trial for efficacy and safety of cilostazol on the progression of symptomatic intracranial stenosis comparing clopidogrel

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Apr 2012

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cilostazol (Primary) ; Aspirin; Clopidogrel
  • Indications Embolism and thrombosis; Ischaemic stroke
  • Focus Therapeutic Use
  • Acronyms TOSS-2; TOSS-II

Most Recent Events

  • 29 Mar 2012 Substudy results presented at the 16th International Symposium on Atherosclerosis.
  • 12 Jan 2010 Actual end date (Jan 2009) and actual number of patients (457) added as reported by ClinicalTrials.gov.
  • 12 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top